tiprankstipranks
Advertisement
Advertisement

JP:4583 Stock Latest News

Chiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist
Company AnnouncementsChiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist
13d ago
4583
Chiome Bioscience Outlines FY2025 Results and mAb Development Focus
PremiumCompany Announcements
Chiome Bioscience Outlines FY2025 Results and mAb Development Focus
2M ago
4583
Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited
PremiumCompany Announcements
Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited
2M ago
4583
Chiome Bioscience Reports Continued Losses Amidst Declining Sales
PremiumCompany Announcements
Chiome Bioscience Reports Continued Losses Amidst Declining Sales
5M ago
4583
Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update
PremiumCompany Announcements
Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update
5M ago
4583
Chiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment
PremiumCompany AnnouncementsChiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment
5M ago
4583
Chiome Bioscience Reports First Half 2025 Financial Results
Premium
Company Announcements
Chiome Bioscience Reports First Half 2025 Financial Results
8M ago
4583
Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses
Premium
Company Announcements
Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses
11M ago
4583
Chiome Bioscience Updates Financial Results for FY 2024
PremiumCompany Announcements
Chiome Bioscience Updates Financial Results for FY 2024
1y ago
4583
Chiome Bioscience and OmniAb Collaborate on Antibody Research
PremiumCompany Announcements
Chiome Bioscience and OmniAb Collaborate on Antibody Research
1y ago
4583
Chiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges
PremiumCompany Announcements
Chiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges
1y ago
4583
Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy
PremiumCompany Announcements
Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy
1y ago
4583
Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study
PremiumCompany AnnouncementsChiome Bioscience’s Promising Results in CBA-1205 Phase I Study
1y ago
4583
Chiome Bioscience Unveils Promising Cancer Therapy Data
Premium
Company Announcements
Chiome Bioscience Unveils Promising Cancer Therapy Data
1y ago
4583
Chiome Bioscience Secures Licensing Deal with Asahi Kasei
Premium
Company Announcements
Chiome Bioscience Secures Licensing Deal with Asahi Kasei
1y ago
4583
Chiome Bioscience Secures Key Licensing Deal
PremiumCompany Announcements
Chiome Bioscience Secures Key Licensing Deal
1y ago
4583
Chiome Bioscience Revises Forecast Amid Financial Challenges
PremiumCompany Announcements
Chiome Bioscience Revises Forecast Amid Financial Challenges
1y ago
4583
Chiome Bioscience Reports Decreased Half-Year Results
PremiumCompany Announcements
Chiome Bioscience Reports Decreased Half-Year Results
2y ago
4583
Chiome Bioscience Begins Phase I Trial for Cancer Drug
PremiumCompany Announcements
Chiome Bioscience Begins Phase I Trial for Cancer Drug
2y ago
4583

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >